TNFSF10 and urinary bladder carcinoma: Given that TRAIL plays an important role in BCG-induced anti-cancer effects [8] and TRAIL-based therapeutics have entered clinical trials [7], our findings provide a novel strategy to use evodiamine in combination with TRAIL for the treatment of bladder cancer.